TEM's diagnostics growth and expanding data deals support momentum, but sizable GAAP losses and execution challenges could ...

Wondering if Tempus AI at around US$47.82 is starting to look interesting, or if the stock still carries more risk than reward for you. The stock has risen 3.0% over the past week and 4.2% over the ...

Tempus AI is growing fast, but the real debate is whether its healthcare data platform can justify the premium price ...

Tempus AI Inc. TEM stock surged on Thursday. The sharp upward price action follows a major company announcement made on ...

Tempus AI hits multi-year lows despite 500+ PB proprietary healthcare data and precision medicine AI. Click here to read more ...

View Tempus AI, Inc. Class A TEM stock quote prices, financial information, real-time forecasts, and company news from CNN.

Market snapshot and recent moves Tempus AI (TEM) has drawn fresh attention after a strong single-day move, with the stock up about 10% on the latest close at US$52.26, compared with weaker returns ...

Tempus AI Inc (NASDAQ:TEM) is among the best medical AI stocks to buy now. Tempus has partnered with SoftBank, Gilead, and Merck on AI-driven drug development programs. Analysts are growing more ...

Shares of Tempus AI rose after the medical technology company said it was expanding the commercial availability of whole-genome sequencing assay technology to detect and analyze cancer cells in ...

- Proceeds expected to be used to repay in full outstanding loans under the senior secured credit facilities, reducing interest expense and enhancing financial flexibility. Additional proceeds ...